A domestic applicant shall be an institution that is lawfully registered within China and can bear civil liabilities independently, while an overseas applicant is a lawful overseas drug manufacturer.

• 境内申请人应当是在中国境内合法登记并能独立承担民事责任的机构，境外申请人应当是境外合法制药厂商。